Skip to main content

Robert A. Lenz

Equibles does not estimate personal net worth.

Get an email with a short summary when Lb Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get LBRX alerts

About Robert A. Lenz

Robert A. Lenz is recorded as Board Member at Lb Pharmaceuticals Inc (LBRX) since March 6, 2026. Lb Pharmaceuticals Inc reported in an 8-K filed March 10, 2026 that Robert A. Lenz was appointed Class I director, effective March 6, 2026. Lb Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lb Pharmaceuticals Inc includes Heather Turner (CEO and Board Member), Joseph M. Miller (CFO) and Gad Soffer (COO).

“On March 6, 2026, the Board of Directors (the “Board”) of LB Pharmaceuticals Inc (the “Company”) appointed Robert A. Lenz, to the Board, effectively immediately.”
Lb Pharmaceuticals Inc Form 8-K, filed March 10, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Lb Pharmaceuticals Inc

Recent activity